BNP Paribas Financial Markets’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $28 | Hold |
|
|||||
|
2025
Q2 | $51 | Hold |
|
|||||
|
2025
Q1 | $42 | Hold |
|
|||||
|
2024
Q4 | $115 | Hold |
|
|||||
|
2024
Q3 | $202 | Hold |
|
|||||
|
2024
Q2 | $208 | Hold |
|
|||||
|
2024
Q1 | $337 | Sell |
|
|||||
|
2023
Q4 | $1.71K | Sell |
|
|||||
|
2023
Q3 | $3.16K | Buy |
|
|||||
|
2023
Q2 | $1.58K | Buy |
|
|||||
|
2023
Q1 | $1.22K | Buy |
|
|||||
|
2022
Q4 | $1.37K | Buy |
|
|||||
|
2022
Q3 | $454 | Sell |
|
|||||
|
2022
Q2 | $3.56K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $16.9K | Hold |
|
|||||
|
2018
Q4 | $22.6K | Sell |
|
|||||
|
2018
Q3 | $140K | Hold |
|
|||||
|
2018
Q2 | $122K | Buy |
|